The HORIBA Medical Segment designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.
HORIBA supports Women in Science. Read their passionate stories and learn how female scientists conquered barriers to flourish in technology and science.
This time, an interview of Mandy Campbell, HORIBA Medical Marketing Manager in UK is featured...Read
Two parties have signed a contract to meet the company’s requirements of biological samples for the validation and development of IVD solutions and analyzers.Read
HORIBA Medical and LABORATORIO ECHEVARNE, one of the major Laboratory Medicine providers in Europe have signed a multi-year, multi-site contract for the supply of the high range fully automated Hematology analyzers during the EuroMedLab congress.more
Based on innovative ‘data mining’ techniques and combined with Full Blood Count, the Malaria suspicion flag is optionally available on both the ABX Pentra XL 80 and Pentra XLR.more
HORIBA Medical announces the availability of a D-Dimer reagent for their semi-automated Hemostasis instruments.more
HORIBA Medical presents “Yumizen”, the new brand for all future analyzers and solutions including Hematology, Clinical Chemistry and Care Products.
Choose Yumizen, you will stay zen.More